Mitochondria constantly respond to changes in substrate availability and energy utilization
to maintain cellular ATP supplies, and at the same time control reactive oxygen radical (ROS) …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2, has spread globally, and no proven treatments are available. Convalescent plasma …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2, has spread globally, and proven treatments are limited. Transfusion of …

The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
highlights the urgent need for assays that detect protective levels of neutralizing antibodies. We …

To determine the effect of COVID-19 convalescent plasma on mortality, we aggregated
patient outcome data from 10 randomized clinical trials, 20 matched control studies, 2 dose-…

Coronavirus disease 2019 (COVID-19) convalescent plasma has emerged as a promising
therapy and has been granted Emergency Use Authorization by the US Food and Drug …

The receptor‐binding domain (RBD) of the severe acute respiratory syndrome coronavirus
2 spike (S) protein plays a central role in mediating the first step of virus infection to cause …

Importance Red blood cell transfusion is a common medical intervention with benefits and
harms. Objective To provide recommendations for use of red blood cell transfusion in adults …

Phosphorylation of respiratory chain components has emerged as a mode of regulation of
mitochondrial energy metabolism, but its mechanisms are still largely unexplored. A recently …

Newly emerged pathogens such as SARS-CoV-2 highlight the urgent need for assays that
detect levels of neutralizing antibodies that may be protective. We studied the relationship …